New research sheds light on how ketamine affects the brain by targeting a specific NMDA receptor subtype, GluN1-2B-2D.

RAs, originally for diabetes, may impact brain health, finding potential benefits for dementia and addiction but inconsistent ...

As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...

Who hasn't been there? The big meal is over, you're full, but the craving for sweets remains. Researchers from the Max Planck ...

"There are already drugs that block opiate receptors in the brain, but the weight loss is less than with appetite-suppressant injections," Fenselau noted. "We believe that a combination with them ...

A groundbreaking study suggests that IBS might be more of a brain issue than a gut disorder. Researchers found that ...

It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...

Who hasn't been there? The big meal is over, you're full, but the craving for sweets remains. Researchers from the Max Planck Institute for Metabolism Research have now discovered that what we call ...

Naloxone is a fantastic tool in reducing opioid deaths, but gentler versions would be helpful for fighting overdose ...

This is your brain on drugs — and it’s not good. A new study billed as the “largest of its kind” used brain imaging technology to examine the effects of recent and lifetime cannabis use on ...

Scientists have discovered a potential new drug that could help people with Alzheimer’s disease by improving memory and ...